Melbourne Australia | 21 March 2025 — Telix today announces that the United States (U.S.)...
Author - David Miller
Novartis Receives Third FDA Approval for Oral Fabhalta...
Basel, March 20, 2025 – Novartis today announced that oral Fabhalta (iptacopan) has received U.S...
FDA Approves Tremfya (guselkumab) for Adult Patients with...
HORSHAM, Pa. (March 20, 2025) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S...
Alnylam Announces FDA Approval of Amvuttra (vutrisiran), the...
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Mar. 20, 2025– Alnylam Pharmaceuticals, Inc...
FDA Approves Pembrolizumab for HER2 Positive Gastric or...
On March 19, 2025, the Food and Drug Administration granted traditional approval to pembrolizumab...
FDA Approves Arbli (losartan potassium) Oral Suspension as the...
TAMPA, FL, March 18, 2025 (GLOBE NEWSWIRE) — Scienture Holdings, Inc. NASDAQ: SCNX), a...
ANI Pharmaceuticals Announces FDA Approval for Expansion of...
BAUDETTE, Minn., March 14, 2025 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (Nasdaq: ANIP)...
FDA Approves Expanded Use of Soliris (eculizumab) for Pediatric...
New York, March 10, 2025 – The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and...
FDA Approves Omlyclo (omalizumab-igec), an Interchangeable...
JERSEY CITY, N.J., March 9, 2025 /PRNewswire/ — Celltrion today announced the U.S. Food and...
scPharmaceuticals Announces FDA Approval of Supplemental New...
BURLINGTON, Mass., March 06, 2025 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH)...